Exagen Inc. (NASDAQ:XGN) Q2 2025 Earnings Conference Call July 29, 2025 8:30 AM ET
Company Participants
Jeffrey G. Black – CFO & Corporate Secretary
John Aballi – CEO, President & Director
Ryan Douglas – Investors Relations Officer
Conference Call Participants
Kyle Alexander Mikson – Canaccord Genuity Corp., Research Division
Margarate Elizabeth Boeye – William Blair & Company L.L.C., Research Division
Ross Everett Osborn – Cantor Fitzgerald & Co., Research Division
William Ruby – TD Cowen, Research Division
Operator
Greetings, and welcome to the Exagen Inc. Q2 2025 Earnings Call. [Operator Instructions]. As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Ryan Douglas, Investor Relations. Thank you. You may begin.
Ryan Douglas
Good morning, and thank you for joining us. Earlier this morning, Exagen Inc. released financial results for the quarter ended June 30, 2025. John Aballi, our President and Chief Executive Officer; and Jeff Black, our Chief Financial Officer, will host this morning’s call.
A recording of today’s call and the press release announcing the quarterly results can be found on the company’s website at www.exagen.com. As today’s call includes forward-looking statements, we encourage you to review the statements contained in today’s press release and the risks and uncertainties described in our SEC filings which identify certain factors that may cause the company’s actual events, performance and results to differ materially from those contained in the forward-looking statements made on today’s call.
In addition, we will discuss non-GAAP financial measures on this call. Descriptions of these non-GAAP financial measures and the reconciliations of GAAP to non-GAAP financial measures are included in today’s press release.
I will now turn the call over to John.
John Aballi
Good morning, and thank you for joining us. We’re excited to report another strong quarter at Exagen, highlighted by record
#Exagen #XGN #Earnings #Call #Transcript